In the same year, Lee et al. demonstrated in a model of rheumatoid arthritis (RA) the immunosuppressive efficacy of TCZ-ALD, an ADC that targets the IL-6 receptor (IL-6R) and is conjugated to the small molecule alendronate. Here, IL6R is linked to rheumatoid arthritis.